Cite
HARVARD Citation
Calvaruso, V. et al. (n.d.). Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with mild-moderate fibrosis, with or without glucose abnormalities: interim results of the EGG18 study. Digestive and liver disease. pp. e26-e27. [Online].